FDA restricts JJ's COVID-19 vaccine due to blood clot risk
The Food and Drug Administration said the shot should only be given to adults who cannot receive a different vaccine or specifically request JJ's vaccine. U.S. authorities for months have recommended that Americans get Pfizer or Moderna shots instead of JJ's vaccine. Pfizer sets up Asia's first global drug development centre in Chennai
The centre, which employs 250 scientists and technicians, would develop innovative formulations, small molecules and active pharmaceutical ingredients (APIs).
Pfizer's profit grows by 61% in first qtr; company revises 2022 forecast
Sales of Pfizer's COVID-19 vaccine and treatment pushed the drugmaker well past expectations in the first quarter, as profit grew 61per cent. PFIZER LTD. - 500680 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aditya Birla Sun Life Mutual Fund PFIZER LTD. - 500680 - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2
Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company PFIZER LTD. 2 CIN NO. L24231MH1950PLC008311 3 Report filed for FY 2021-2022 Details of the Current block (all figures in Rs crore): 4 2 - year block period (Specify financial years)* 2020-21,21-22 5 Incremental borrowing done in FY (T)(a) 0.00 6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00 7 Actual borrowing done through debt securities in FY (T)(c) 0.00 8 Shortfall in the borrowing through debt securities, if any, for FY (T - 1) carried forward to FY (T) (d) 0 8Quantum of (d), which has been met from (c)(e)* 0 9 Shortfall, if any, in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T - 1) which was carried forward to FY(T)}(f) = (b) - [(c) - (e)]{ If the calculated value is zero or negative, write 'nil'}* 0 Details of penalty to be paid, if any, in respect to previous block (all figures in Rs crore): 2 - year Block period (Specify financial years)2020-21,21-22 Amount of fine to be paid for the block, if applicable Fine = 0.2% of {(d) - (e)}#0.00 Name of the Company Secretary :-Prajeet NairDesignation :-Company Secretary and Compliance Officer Name of the Chief Financial Officer :- Milind Patil Designation : -Executive Director Finance and Chief Financial Officer Date: 28/04/2022 Covid cases up 3 per cent on 24-hour basis, Pfizer's new anti-viral reportedly gets regulator nod
Number of active cases at 15,079, with daily positivity rate increasing to 0.56 per cent WHO recommends Pfizer's antiviral, calls for transparency on deals
Remdesivir gets a leg-up, too, for use in mild or moderate patients
Johnson & Johnson suspends its Covid-19 vaccine sales forecasts
Johnson & Johnson is suspending sales forecasts for its COVID-19 vaccine only a few months after saying the shot could bring in as much as USD 3.5 billion this year. The health care giant said Tuesday that a global supply surplus and demand uncertainty prompted the move, which will not affect the company's operational earnings per share guidance. J&J's one-shot vaccine brought in USD 457 million in global sales during the first quarter, with most of that coming from outside the United States. The vaccine brought in only USD 75 million in sales in the US, or about 25 per cent less than what it rang up after debuting in last year's first quarter. J&J has said it doesn't intend to profit from the vaccine. But it said in January that it could bring in between USD 3 billion and USD 3.5 billion in sales this year, as countries continue to fight variants of the virus. The vaccine brought in USD 2.38 billion in sales last year. Vaccine options from rival drugmakers Pfizer and... PFIZER LTD. - 500680 - Compliance Certificate - Regulation 40 (9) Of The SEBI (LODR) Regulations, 2015
In compliance with Regulation 40 (9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith the Certificate given by the Practicing Company Secretary, M/s. Manish Ghia & Associates, for the year ended March 31, 2022.
Pfizer to seek Covid-19 booster shots for healthy 5- to 11-year-olds in US
Now Pfizer says new data shows healthy 5- to 11-year-olds could benefit from another kid-sized shot